CathWorks has developed a mapping platform for coronary arteries that streamlines cases, with a subscription model that can potentially accelerate its adoption and transition doctors away from traditional catheters, CEO Ramin Mousavi explains to Bloomberg Intelligence. In this Vanguards of Health Care podcast episode, Mousavi sits down with BI analyst Matt Henriksson to talk about CathWorks, how the FFRangio technology takes a routine angiogram exam, or X-ray, and its in-house AI algorithm to create a 3D map of the arteries. He also discusses how the FastFFR clinical trial showed that using fractional flow reserve measurements has a 93% diagnostic accuracy, and the next steps in implementing a Netflix-style commercial model through its partnership with Medtronic.